Injective INJ
Current Price
$6.44 -4.29%
$0.8400 Daily Range (13.04%)
$6.12$6.96
$122.98M Daily Volume
1,361 BTC
Vol/MktCap: 19.11%
Market Performance
0.15% Relative BTC Volume
The total volume of Injective is $122.98M over the past 24 hours, compared to $82.39B total Bitcoin volume.
Hourly Moving Average
8 SMA $6.63 -2.90%
13 SMA $6.60 -2.45%
21 SMA $6.60 -2.44%
55 SMA $6.53 -1.33%
144 SMA $6.69 -3.80%
Price Performance
+3.01% 1 Hour Change
$6.44 from $6.25
-12.22% 7 Day Change
-$0.7873 from $7.23
-2.86% 14 Day Change
-$0.1843 from $6.62
-27.17% 30 Day Change
-$1.75 from $8.19
All Time High
March 14, 2024
$52.62 -87.80%
-$46.20 vs. now
24H Change
-29.10M USD -4.33%
-322 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.01 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
18.80M INJ
traded over past 24 hours
18.80% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $6.29, reflecting a significant drop of 5.71% in the last 24 hours. The price has fluctuated within a range of $6.28 to $6.96 during this period, indicating volatility but a lack of upward momentum.
The trading volume over the last 24 hours stands at approximately 110.5 million, equating to a volume-to-market cap ratio of 17.58%. This suggests that the market is experiencing a relatively active trading session, although the price decline indicates selling pressure outweighs buying interest.
The hourly moving averages indicate a bearish trend, with the 8 SMA at $6.59 showing a decrease of 4.53%, and the 144 SMA at $6.73 reflecting a more significant decline of 6.60%. These trends suggest that the short-term momentum is negative, and the asset is struggling to regain any upward traction.
Both the 1-hour and 7-day Relative Strength Index (RSI) readings are at 39 and 44, respectively, indicating that INJ is approaching oversold territory but has not yet entered it. The 7-day price change of -16.83% and the 30-day change of -29.38% further underline a downtrend, which can lead to investor caution.
Given the significant price depreciation since its all-time high of $52.62 in March 2024, the current valuation reflects a lack of bullish sentiment in the market. The technical indicators and recent performance suggest that INJ may face further declines if selling pressure continues, particularly with weak RSI readings and downward-moving averages.
In conclusion, the analysis indicates a bearish outlook for Injective (INJ). Therefore, the rating is a Sell, as the combination of declining price action, negative momentum indicators, and the overall market sentiment suggests that further losses are likely in the near term.
The trading volume over the last 24 hours stands at approximately 110.5 million, equating to a volume-to-market cap ratio of 17.58%. This suggests that the market is experiencing a relatively active trading session, although the price decline indicates selling pressure outweighs buying interest.
The hourly moving averages indicate a bearish trend, with the 8 SMA at $6.59 showing a decrease of 4.53%, and the 144 SMA at $6.73 reflecting a more significant decline of 6.60%. These trends suggest that the short-term momentum is negative, and the asset is struggling to regain any upward traction.
Both the 1-hour and 7-day Relative Strength Index (RSI) readings are at 39 and 44, respectively, indicating that INJ is approaching oversold territory but has not yet entered it. The 7-day price change of -16.83% and the 30-day change of -29.38% further underline a downtrend, which can lead to investor caution.
Given the significant price depreciation since its all-time high of $52.62 in March 2024, the current valuation reflects a lack of bullish sentiment in the market. The technical indicators and recent performance suggest that INJ may face further declines if selling pressure continues, particularly with weak RSI readings and downward-moving averages.
In conclusion, the analysis indicates a bearish outlook for Injective (INJ). Therefore, the rating is a Sell, as the combination of declining price action, negative momentum indicators, and the overall market sentiment suggests that further losses are likely in the near term.
Updated 330 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

US Holding Off On Bitcoin Reserve—Waiting For The World To Move First, Crypto Expert Says
According to industry voices, the US is likely to hold off buying Bitcoin until others move first.

Chainlink’s liquidity map hints at upside – Are buyers ready to push?
LINK could make a bullish stride.

How a single computer file accidentally took down 20% of the internet yesterday – in plain English
Yesterday’s outage showed how dependent the modern web is on a handful of core infrastructure providers.

Crypto Miners in Malaysia Stole $1 Billion in Power Over Five Years
A new parliamentary tally shows power theft tied to crypto mining accelerating sharply since May’s warnings of rising illicit activity.